Cargando…

Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study

BACKGROUND: Bisphosphonate medications, including alendronate, ibandronate and risedronate administered orally and zoledronate, administered intravenously, are commonly prescribed for the treatment of osteoporosis based on evidence that, correctly taken, bisphosphonates can improve bone strength and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bishop, Simon, Narayanasamy, Melanie Jay, Paskins, Zoe, Corp, Nadia, Bastounis, Anastasios, Griffin, Jill, Gittoes, Neil, Leonardi-Bee, Jo, Langley, Tessa, Sahota, Opinder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540377/ https://www.ncbi.nlm.nih.gov/pubmed/37770860 http://dx.doi.org/10.1186/s12891-023-06865-1

Ejemplares similares

Assessing the Effectiveness of Bisphosphonates for the Prevention of Fragility Fractures: An Updated Systematic Review and Network Meta‐Analyses
por: Bastounis, Anastasios, et al.
Publicado: (2022)

Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis
por: Paskins, Zoe, et al.
Publicado: (2020)

Comparing medication adherence in patients receiving bisphosphonates for preventing fragility fractures: a comprehensive systematic review and network meta-analysis
por: Bastounis, A., et al.
Publicado: (2022)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Acceptability of, and preferences for, remote consulting during COVID-19 among older patients with two common long-term musculoskeletal conditions: findings from three qualitative studies and recommendations for practice
por: Paskins, Zoe, et al.
Publicado: (2022)

The Acute VertEbRal AugmentaTion (AVERT) study: protocol for a randomised controlled, feasibility trial of spinal medial branch nerve block in hospitalised older patients with vertebral fragility fractures
por: Tan, Chia Wei, et al.
Publicado: (2022)

Fracture liaison services: improving outcomes for patients with osteoporosis
por: Walters, Samuel, et al.
Publicado: (2017)

The effect of low-dose intravenous bisphosphonate treatment on osteoporosis in children with quadriplegic cerebral palsy
por: Moon, Soon Jeong, et al.
Publicado: (2017)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial
por: Rowlands, Martin, et al.
Publicado: (2013)

Understanding vitamin D deficiency
por: Sahota, Opinder
Publicado: (2014)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Long-term use of bisphosphonates in osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2017)

Long-term use of bisphosphonates in osteoporosis
por: Alwahhabi, Basmah K., et al.
Publicado: (2017)

Comparison of the Prescribing Pattern of Bisphosphonate and Raloxifene in Korean Women with Osteoporosis: From a National Health Insurance Claims Database
por: Kim, Jungmee, et al.
Publicado: (2015)

Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study
por: Eisenstein, Neil, et al.
Publicado: (2017)

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
por: Grey, Andrew, et al.
Publicado: (2006)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Physicians’ perspectives on the treatment of osteoporosis patients with bisphosphonates
por: Gu, Tao, et al.
Publicado: (2016)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

ERT, HRT, Raloxifine, Calcitonin, or Bisphosphonates for Osteoporosis
por: Curtiss, Frederic R.
Publicado: (2003)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada
por: Burden, A. M., et al.
Publicado: (2011)

Are we achieving the standards of good nutritional care for older people in hospital with fragility fractures?
por: Sahota, Amunpreet, et al.
Publicado: (2023)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Incident acute pseudogout and prior bisphosphonate use: Matched case–control study in the UK-Clinical Practice Research Datalink
por: Roddy, Edward, et al.
Publicado: (2017)

A 3-year retrospective analysis of patients admitted with clinical vertebral fragility fractures across hospitals in England, UK
por: Tan, Chia Wei, et al.
Publicado: (2023)

UK clinical guideline for the prevention and treatment of osteoporosis
por: Gregson, Celia L., et al.
Publicado: (2022)

Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Correction: UK clinical guideline for the prevention and treatment of osteoporosis
por: Gregson, Celia L., et al.
Publicado: (2022)

Expressed information needs of patients with osteoporosis and/or fragility fractures: a systematic review
por: Raybould, Grace, et al.
Publicado: (2018)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Bock, Oliver, et al.
Publicado: (2008)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010)

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
por: Newcomb, P A, et al.
Publicado: (2010)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009)

Bisphosphonates as treatment of secondary osteoporosis in children: a case series
por: Soesanti, Frida, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rfpgld63vpvlj9p57uqfjo0mr7